The study will investigate the possible nephroprotective effect of curcumin when added to patients infected by MDR Gram-negative bacteria and require intravenous colistin therapy, curcumin will be given concurrently with colistin and discontinued at the same time as Colistin.
The goal of this study is to investigate the possible nephroprotective effect of curcumin in critically ill patients receiving colistin.